This is a prospective, single-arm, multi-center, international, open-label, non-randomized, clinical study. The aim of the study is to assess the safety and efficacy of the use of the Hairstetics hair implant device in subjects affected with hair loss.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
100
Cabinet du Dr G. Beilin
Paris, France
RECRUITINGCabinet médical du Dr Jack Smadja
Paris, France
RECRUITINGGeorges Mandel Office Surgery Clinic
Paris, France
Acceptable number, duration and severity of expected adverse device/procedure effects
Time frame: 3 months following implantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Paras hospital
Gurgaon, India
RECRUITINGFortis Hospital
New Delhi, India
RECRUITINGEgoclinic
Bucharest, Romania
RECRUITINGMetropolitan hospital
Bucharest, Romania
RECRUITINGRevere clinic
London, United Kingdom
RECRUITING